Biocept, Inc.
BIOCQ
$0.00
$0.000.00%
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 49.17% | 26.41% | 32.39% | -42.94% | -354.52% |
| Total Depreciation and Amortization | -39.74% | 40.18% | 7.62% | 4,622.22% | -101.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -580.70% | -43.67% | 341.73% | -85.11% | -51.51% |
| Change in Net Operating Assets | 8,370.00% | -99.55% | -54.18% | 88.90% | 497.00% |
| Cash from Operations | 50.18% | -46.02% | -4.10% | -0.87% | -333.48% |
| Capital Expenditure | -6.59% | 33.09% | 61.80% | -64.06% | -121.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 75.82% | 33.09% | 61.80% | -64.06% | -121.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -152.56% | 68.67% | -20.29% | -30.74% | -77.24% |
| Issuance of Common Stock | 798.48% | 39,500.00% | -99.31% | 54.26% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,731.48% | 121.72% | -56.72% | -24.93% | -42.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.70% | -19.50% | -4.42% | -5.80% | -257.32% |
